Loading company…
Cambridge, Massachusetts biotech developing NK cell therapeutics, including an anti-LLT1 monoclonal antibody candidate.
Zumutor Biologics Inc. was founded in 2013 and is headquartered in Cambridge, Massachusetts. CEO and founder Kavitha Rodrigues leads the company, which develops NK cell therapeutics using its INABLR human antibody platform. Its lead candidate, an anti-LLT1 monoclonal antibody, targets malignancies including prostate cancer, B-cell lymphoma and glioblastoma. In June 2026, it raised USD 7.3 million in pre-Series B funding co-led by Accel, bharat innovation fund and Premjiminvest. The directory lists it at the Series A stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in